Sunday, September 12, 2021 2:11:11 AM
He was appointed as Chief Commercial Officer of the Company, with effective from July 10, 2017. Herbst brings with him more than 20 years of experience leading commercial strategies to drive sales, marketing, support and technical teams to achieve accelerated revenue growth, lasting customer relationships and industry leading results, in particular leading the successful launch of an extensive number of products for the veterinary industry. He will lead the commercial strategic launch for Zomedica diagnostic, point of care and therapeutic product offerings. Prior to joining Zomedica, Herbst was the Executive Senior Vice President of Sales and Marketing at i4C Innovations. Before that, he served as Executive Senior Director and Head of U.S. Sales at IDEXX Laboratories, where he was responsible for inclines and reference lab diagnostics, point of care solutions, and information technologies and digital radiography solutions. Herbst also held commercial leadership roles in patient monitoring, pharmacy and diagnostics with Omnicare Specialty Care Group and Life Systems. He holds a BS in business from the University of Arizona.
Executive Since 2017
734 369 2555 http://www.zomedica.com
Recent ZOM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:32:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 07:54:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:17:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 04:03:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/20/2024 11:12:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:16:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:11:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:07:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:06:12 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:18:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:22:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:49 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM